Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate

Title
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 68, Issue 22, Pages 9280-9290
Publisher
American Association for Cancer Research (AACR)
Online
2008-11-14
DOI
10.1158/0008-5472.can-08-1776

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started